Key points

• No incontrovertible or solid evidence supports preventive interventions in high-risk populations. Current opinion, based on known risk factors, suggests that preventing exposure to sources of ultraviolet light such as sunlight may reduce the risk of developing melasma.

• No incontrovertible evidence supports any therapeutic intervention in pregnant or breastfeeding women. Current opinion suggests that such women with melasma may benefit from using broad-spectrum sunscreens and avoiding exposure to ultraviolet light such as sunlight.

2. Estrada-Castanon R, Torres-Bibiano B, Alarcon-Hernandez H et al. Epidemiología cutánea en dos sectores de atención médica en Guerrero, Mexico. Dermato Rev Mex 1992;36:29-34.

3. Failmezger C. Incidence of skin disease in Cuzco, Peru. Int J Dermatol. 1992;31:560-1.

4. Halder RN, Grimes PE, McLaurin CI, Kress MA, Kennery JA Jr. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis 1983;32:388-90.

5. Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol. 1986; 15:894-9.

6. Bleehem SS. Disorders of skin colour. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of Dermatology, 6th ed. Oxford: Blackwell Science, 1998:1753-1815.

7. Resnick S. Melasma induced by oral contraceptive drugs. JAMA 1967;199:601-5.

8. Escoda ECJ. Chloasma from progestational oral contraceptives. Arch Dermatol 1967;87:486.

9. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Minhm MC Jr. Melasma a clinical, light microscopic, ultrastructural and immunofluorescence study. J Am Acad Dermatol 1981;4:698-710.

10. Vazquez M, Maldonado H, Benaman C, Sanchez JL. Melasma in men: a clinical and histologic study. Int J Dermatol 1988;27:25-7.

11. Perez M, Samchez JL, Aguilo F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol 1983;81:543-5.

12. Lufti RJ, Fridmanis M, Misrunas AL. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of melasma. J Clin Endocrinol Metab 1985;61:28-31.

13. Smith AG, Shuster S, Thody AJ et al. Chloasma, oral contraceptives, and plasma immunoreactive beta-melanocyte-stimulating hormone. J Invest Dermatol 1977:169-170.

14. Findley GH, Morrison JGL, Simon IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93:613-22.

15. Gilchrest BA, Fitzpatrick TB, Anderson RR, Parish JA. Localization of melanin pigmentation in the skin with Wood's lamp. Br J Dermatol 1977;96:245-8.

16. Fitzpatrick TB. Validity and practicality of sun-reaction types I—VI. Arch Dermatol 1988;124:869-71.

17. Leenutaphong V, Nettakul A, Rattanasuwon P. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial. J Med Assoc Thai 1999;82: 868-75.

18. Graupe K, Verallo RVM, Verallo V, Zaumseil RP. Combined use of 20% azelaic acid cream and 0-05% tretinoin cream in the topical treatment of melasma. J Dermatol Treat 1996;7:235-7.

19. Vazquez M, Sanchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. Cutis 1983;32:92-6.

20. Neering H. Treatment of melasma (cholasma) by local application of a steroid cream. Dermatologica 1975;151:349-53.

21. Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol 1993;129:415-21.

22. Krimbrough-Green CK, Griffiths CEM, Finkel LJ et al. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol 1994;130:727-33.

23. Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azealic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther 1998;20:945-59.

24. Sivayathorn A, Verallo RV, Graupe K. 20% azelaic acid cream in the topical treatment of melasma: A double-blind comparison with 2% hydroquinone. Eur J Dermatol 1995;5:680-4.

25. Piquero-Martin J, Rothe de Arocha J, Beniamini Loker D. Estudio clínico doble ciego en el tratamiento del melasma entre ácido azelaico versus hidroquinona. Med Cut I LA 1988;16:511-14.

26. Ennes SBP, Paschoalick RC, Mota M. A double blind, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma. J Dermatol Treat 2000;11:173-9.

27. Lim JT, Tham SN. Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg 1997;23:177-9.

28. Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessner's solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination. J Am Acad Dermatol 1997;36:589-93.

29. Kakita LS, Lowe NJ. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: A clinical comparison with hydroquinone. Clin Ther 1998;20:960-70.

30. Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg 1999;25:282-4.

31. Poli F, Lakhdar H, Souissi R, Fiquet E, Chanez JF. Clinical evaluation of a depigmenting cream: Trio-D (R) in melasma of the face. Nouv Dermatol 1997;16: 193-7.

32. Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996;22:443-7.

33. Pathak MA. Treatment of melasma with hydroquinone. J Invest Dermatol 1981;76:324.

34. Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser:a pilot study. Dermatol Surg 1999;25:494-7.

35. Hayakawa R, Ueda H, Nozaki T etal. Effects of combination treatment with vitamins E and C on cholasma and pigmented contact dermatitis. A double blind controlled clinical trial. Acta Vitaminol Enzymol 1981;3:31-8.

Was this article helpful?

0 0
Natural Treatments For Psoriasis

Natural Treatments For Psoriasis

Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.

Get My Free Ebook


Post a comment